Roche News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.06.22	Roche Launches VENTANA DP 600 Slide Scanner For Digital Pathology (RTTNews)
16.06.22	Roche Announces Launch Of Human Papillomavirus Self Sampling Solution - Quick Facts (RTTNews)
16.06.22	Genentech : Alzheimer's Prevention Initiative Study Of Crenezumab Didn't Show Clinical Benefit (RTTNews)
10.06.22	AbbVie : Data Shows Venclyxto/Venclexta Combination Sustained PFS In Chronic Lymphocytic Leukemia (RTTNews)
09.06.22	FDA OKs Foundation Medicine's FoundationOne CDx As Companion Diagnostic For Roche's Rozlytrek (RTTNews)
08.06.22	Roche: EU Approves Lunsumio To Treat Relapsed Or Refractory Follicular Lymphoma (RTTNews)
31.05.22	Genentech: FDA Approves Evrysdi For Babies Under Two Months Of Age With Spinal Muscular Atrophy (RTTNews)
26.05.22	EU Approves Roche's Polivy Combination For Previously Untreated Diffuse Large B-cell Lymphoma (RTTNews)
11.05.22	Genentech : Phase III Study In Non-Small Cell Lung Cancer Fails To Meet Co-primary Endpoint (RTTNews)
29.04.22	Genentech: 3-yr Data Reinforces Efficacy, Safety Of Evrysdi In Infants With Type 1 SMA (RTTNews)
25.04.22	Roche Q1 Group Sales Up 11% At CER (RTTNews)
05.04.22	Roche to showcase the future of diagnostic solutions at EuroMedLab, 10 to 14 April 2022 Munich at ICM International Congress Center (PR Newswire)
04.04.22	Genentech : Ocrevus Data Show Benefit In Disability Progression & Cognitive Decline In SPMS & PPMS (RTTNews)
04.04.22	Genentech's Actemra Intravenous Gets FDA Priority Review To Treat COVID-19 In Hospitalized Adults (RTTNews)
30.03.22	Roche: Phase III SKYSCRAPER-02 Study In ES-SCLC Fails To Meet Co-primary Endpoint (RTTNews)
25.03.22	Roche: CHMP Recommends Approval Of Polivy Combination In Treatment Of Diffuse Large B-cell Lymphoma (RTTNews)
25.03.22	Bristol Myers Squibb, Roche Collaborate To Advance Personalised Healthcare (RTTNews)
25.03.22	Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions (PR Newswire)
17.03.22	Roche Provides Molecular Testing Solutions To Identify & Differentiate SARS-CoV-2 Omicron Variants (RTTNews)
16.03.22	Roche Announces New Positive Long-term Efficacy And Safety Data For Evrysdi In SMA (RTTNews)
23.02.22	Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark (PR Newswire)
11.02.22	Genentech : Vabysmo & Susvimo Data Reinforce Potential To Maintain Vision With Fewer Treatments (RTTNews)
03.02.22	Roche FY Profit Down 1% - Quick Facts (RTTNews)
31.01.22	Roche: FDA Approves Vabysmo To Treat Two Vision-threatening Retinal Conditions (RTTNews)
24.01.22	Genentech's Faricimab Improved, Maintained Vision In Two Causes Of Vision Loss (RTTNews)
12.01.22	Roche Launches Cobas Pulse System In Select Countries - Quick Facts (RTTNews)
11.01.22	Roche Unveils Cobas Infinity Edge, Digital Ecosystem For Point Of Care Professionals (RTTNews)
27.12.21	Biotech Stocks Facing FDA Decision In January 2022 (RTTNews)
26.12.21	Roche COVID-19 At-Home Test Granted FDA Emergency Use Authorization (RTTNews)
20.12.21	Why Lineage Cell Therapeutics Is Rising In Pre-market? (RTTNews)
17.12.21	Roche Gets CE Mark For Use Of Saliva Samples With Cobas SARS-CoV-2 Qualitative Test (RTTNews)
17.12.21	Roche receives CE mark for the use of saliva samples with cobas SARS-CoV-2 Qualitative test on cobas 6800/8800 Systems (PR Newswire)
15.12.21	Roche launches the first infectious disease tests and cobas omni Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark (PR Newswire)
14.12.21	Genentech's Polivy Combination Reduces Risk Of Disease Worsening Or Death By 27% In DLBCL (RTTNews)
11.12.21	Genentech : Phase I/II Result Shows Mosunetuzumab Induces Complete Response Rates In Blood Cancer (RTTNews)
10.12.21	Roche Posts Encouraging Follow-up Data From Phase II CITYSCAPE Trial - Quick Facts (RTTNews)
09.12.21	Roche : Novel Approach To Be Launched In Quebec To Study Causes And Consequences Of COVID-19 (RTTNews)
07.12.21	Recursion Announces Collaboration With Roche, Genentech In Neuroscience And Oncology (RTTNews)
07.12.21	EC Approves Roche's Tocilizumab To Treat Patients With Severe Covid-19 (RTTNews)
07.12.21	Roche Introduces AI-based Research Use Only Algorithms Developed For Breast Cancer (RTTNews)
07.12.21	Roche announces the release of its newest artificial intelligence based digital pathology algorithms to aid pathologists in evaluation of breast cancer markers, Ki-67, ER and PR (PR Newswire)
06.12.21	Roche : CHMP Recommends EU Approval Of Actemra/RoActemra To Treat Severe COVID-19 (RTTNews)
06.12.21	Roche To Launch New Test Kits To Detect, Differentiate Between Covid-19 And Influenza Viruses (RTTNews)
18.11.21	Roche Launches New Molecular Diagnostics System Cobas 5800 (RTTNews)
04.11.21	Novartis To Sell 53.3 Mln Roche Shares To Roche For $20.7 Bln (RTTNews)
28.10.21	Roche, Zur Rose Collaborate To Improve Everyday Therapy Management For People Living With Diabetes (RTTNews)
22.10.21	Roche's VENTANA PD-L1 Assay Gets FDA Approval As Companion Diagnostic For Tecentriq In NSCLC (RTTNews)
20.10.21	Roche Q3 Group Sales Rise; Lifts FY21 Outlook - Quick Facts (RTTNews)
18.10.21	Roche Adds Ibex's Image Analysis Tools To Its NAVIFY Digital Pathology Menu - Quick Facts (RTTNews)
18.10.21	Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu
16.09.22		Roche-Aktie gewinnt: Moody's hebt Bonitätseinstufung für Roche an
25.04.22		Roche-Aktie leichter: Umsatz übertrifft Erwartungen

25.06.24

Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch

10.06.24

Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu

21.05.24

Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status

11.12.23

Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor

02.02.23

Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet

27.12.22

Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu